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ABSTRACT 
A Left Ventricular Assist Device (LVAD) is a mechanical pump that provides temporary 
circulatory support when used as bridge-to-transplantation and relieves workload demand placed 
on a failing heart allowing for myocardia recovery when used as destination therapy. Stroke is 
the most devastating complication after ventricular assist device (VAD) implantation, with an 
incidence of 14-47% over 3-6 months, despite improvements in device design and 
anticoagulation. This complication due to thrombus formation and subsequent transport through 
the vasculature to cerebral vessels continues to limit the widespread implementation of VAD 
therapy. Patient-specific computational fluid dynamics (CFD) analysis may elucidate ways to 
reduce this risk. 
 A multi-scale model of the aortic circulation was employed to examine the effects 
on flow conditions resulting from varying the VAD cannula implantation location and angle of 
incidence of the anastomosis to the ascending aorta based on a patient-specific geometry 
obtained from CT scans. The purpose of this study is to numerically investigate tailoring cannula 
implantation with the aim of reducing the number of thrombi reaching cerebral vessels (vertebral 
and carotid arteries), thereby reducing incidence of stroke in LVADs. The multi-scale 
computation consists of a 0D lumped parameter model (LPM) of the circulation modeled via a 
50 degree of freedom (DOF) electrical circuit analogy that includes an LVAD model coupled to 
a 3D computational fluid dynamics model of the circulation. An in-house adaptive Runge-Kutta 
method is utilized to solve the 50 DOF LPM, and the StarCCM+ CFD code is utilized to solve 
the flow field. This 0D-3D coupling for the flow is accomplished iteratively with the 0D LPM 
providing the pulsatile boundary conditions that drive the 3D CFD time-accurate computations 
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of the flow field. The 0D-3D computations are carried out in a parallel environment on a multi-
node cluster computational platform. Investigated angle configurations include cannula 
implantations at 60° and 90° to the right lateral wall of the ascending aorta. We also considered 
placements of the VAD cannula along the ascending aorta in which distances of the VAD 
anastomosis is varied relative to the takeoff of the innominate artery.  We implemented a mixed 
Eulerian-Lagrangian particle-tracking scheme to quantify the number of stroke-inducing 
particles reaching cerebral vessel outlets and included flow visualization through streamlines to 
identify regions of strong vorticity and flow stagnation, which can promote thrombus formation. 
Thrombi were modeled as spheres with perfectly elastic interactions numerically released 
randomly in time and space at cannula inlet plane. Based on clinical observation of the range of 
thrombus sizes encountered in such cases, particle diameters of 2.0mm, 3.0mm and 5.0mm were 
investigated in our numerical computations. Pulsatile flow results for aforementioned angles 
suggest that a 90° cannula implementation causes flow impingement on the left lateral aortic wall 
and appears to be highly thrombogenic due to large momentum losses and zones of large re-
circulation and that shallow and intermediate cannula angles promote more regular flow carrying 
particles towards the lower body potentially reducing stroke risk. Results are presented from this 
detailed study accompanied with statistical analysis of the significance of stroke risk reduction 
under various implantation scenarios. Indications from this pulsatile numerical study suggest that 
up to a 50% reduction in stroke rate can be achieve with tailoring of cannula implantation. 
Results are consistent with significant reduction in stroke incidence achieved by tailoring 
cannula implantation as reported in previous steady flow computations carried out by our group. 
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As such, results of this study suggest that a simple surgical maneuver in the process of VAD 
implantation may significantly improve patient life.  
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1 CHAPTER 1: INTRODUCTION 
Among all possible malfunctions of bodily organs, heart failure, a condition wherein 
cardiac output cannot satisfy corporal requirement, is the most disconcerting. Dependent upon 
the condition of the heart, a by-pass is one consideration. In extremis, transplant becomes the 
best probable solution. Donor compatibility is necessary in order for this procedure to be 
successful leading to long wait times while seeking donor compatibility and availability. In such 
cases, a Ventricular Assist Device (VAD) can be implemented as a bridge to transplantation 
(Figure 1, a-b). Continuous flow pump have shown to be a promising and durable destination 
therapy. Depending on the workload they almost entirely nullify pulsatile effects, which have 
been a major cause to thrombo-embolism. In addition VADs been seen to allow room for 
myocardia recovery. While Ventricular Assist Devices are capable, their efficiency depends 
upon fluid composition and flow mechanics, and despite improved device design and anti-
coagulation treatment, a patient is likely to suffer a thrombo-embolism within a 6 months to a 
one-year period. 
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 (a) 
 
(b) 
Figure 1 - (a) LVAD implantation, (b) LVAD thoracic location. 
Incidence of stroke can be reduced significantly by an adjustment of the VAD outflow 
cannula to direct possible thrombi away from the cerebral vessels towards the other parts of the 
vasculature where they would cause less harm. Steady flow Computational Fluid Dynamic 
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(CFD) analyses have indicated reductions of stroke incidence by as much as 50% dependent 
upon cannula implantation configurations [1,2]. 
1.1 Vascular Organization 
 
An organism’s vasculature serves as a blood flow conduit, carrying oxygen and nutrients 
to the most basic units of the body, supporting additionally, the immune, reparative and other 
regulative processes. Despite complexity and scale variation, vasculature can be separated in 5 
categories: arteries, arterioles, capillaries, venules and veins (Figure 2). 
 
Figure 2 - Circulatory system. 
 3 
In general, the systems is described as having a fractal structure [3]. In this study, the 
interest is focused on the arterial system specifically the aortic arch and its outlets to the upper 
and lower body (Figure 3). Carotid and vertebral arteries supply blood to the head, subclavian 
arteries carry blood to the arms, coronary arteries feed blood to the heart itself and the 
descending aorta supplies blood to the lower extremities. Cardiac output (volumetric flow rates) 
for a typical healthy adult averages at about 5 L/min in a relaxed condition.  
 
Figure 3 - Aortic arch and branching vessels (Layton, et al. 2006). 
A numerical representation of such a variable system (in its entirety) can be quite 
arduous. Hence, by a method of simplification, vessels are “lumped” into empirically derived 
representations such as the Windkessel Model to reduce a 3D problem into a 0D version [3,6]. 
This procedure is referred to as Lumped Parameter Method (LPM). Essentially the Windkessel 
Model draws an analogy between hydrodynamics (in a 3D scale) and electronics (purely in 0D), 
providing a simplified method to compute flow properties based on analogous equations and 
properties in each domain. 
Arterial walls follow a 3-layer pattern. The innermost wall (the intima), an intermediate 
layer (the media) and the adventitia. The intima is mostly composed of endothelial cells, collagen 
and adhesion cells, and is found to be smooth and non-thrombogenic. The intima represents, 
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also, the interface where fluid and structure interact. In the media, muscle fibers, which drive the 
motions of cross-sectional contraction and expansion, are found. The adventitia consists, mainly, 
of fibroplasts and is believed to act as a containment membrane [3].   
1.2 Vascular Diseases 
1.2.1 Heart Failure 
 
Heart failure (HF) occurs when the heart is unable to provide sufficient blood flow output 
to satisfy corporeal requirements. This condition, diagnosed by physical examination, is 
confirmed by echocardiography. Causes include may include heart attack, hypertension, valvular 
heart disease and cardiomyopathy. In general, it is possible to quantify heart failure by means of 
Ejection Fraction (EF), which simply relates the stroke volume (SV) to the end-diastolic volume 
(EDV) and end-systolic volume (ESV) as in Equation 1. 
 
𝐸𝐸𝐸𝐸(%) = 𝑆𝑆𝑆𝑆
𝐸𝐸𝐸𝐸𝑆𝑆
100 (1) 
 𝑆𝑆𝑆𝑆 = 𝐸𝐸𝐸𝐸𝑆𝑆 − 𝐸𝐸𝑆𝑆𝑆𝑆 (2) 
A typical healthy patient has values ranging from 50 – 70 %. An EF below this range 
represents a state of cardiomyopathy.  An individual’s EF tends to decrease gradually due to 
aging, as the heart's efficiency tends to decrease. However, impaired EF or a sharp inefficiency 
are consistent indicators of heart failure. A VAD device is usually implemented in this case to 
support the workload and supply the appropriate amount of blood to regulate bodily functions. 
 
 
 
 5 
1.2.2 Thrombosis Induced Stroke 
 
Blood clotting, an essential occurrence for homeostasis is a normal process, but vessel 
deterioration and tissue malfunction can induce undesirable clotting, which may result in stroke, 
embolism or heart attack. Thrombi generate in two ways: rupture from arteriosclerotic plaques or 
coagulated masses and fatty deposits dislodged from implanted devices such as VADs (Figure 
4). 
 
Figure 4 - Blood cloths generation by arteriosclerotic plaques and blood cloths. 
When thrombi obstruct flow in key vessels, either can be fatal. A subject can suffer a 
stroke in which case cerebral vessels have been occluded or coronary flow is hindered leading to 
a heart attack. In depth understanding of both cases reveals specific flow patterns in regions of 
branching, bends, recirculation and low flow. A detailed flow analysis could help optimizing the 
implementation of VADs to reduce chances of stroke caused by thrombosis. 
1.3 Modeling 
1.3.1 Patient Specific Geometries 
 
In the past, hemodynamic analysis was carried out on idealized vessel structures whose 
results were sound, but limited in applications. With the advance of medical imaging techniques 
such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT scan) obtaining 
high resolution volumetric images of the vascular anatomy is now possible [3,4]. 
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These geometries can be used to generate the required meshing to conduct a CFD 
analysis. Optimized mesh is generated by adaptive methods to reach grid independence and yield 
grater resolution in the regions of interest (branching and bend) [4]. 
1.3.2 Boundary Conditions 
 
In early 3D simulations, boundary conditions (BC) were prescribed for the model inlets 
and outlets in order for the converged solution to match desired conditions. The results, however, 
deviated from the patient measurements.  Modern alternatives are found in MRI that supply in 
vivo measurements for velocity profiles and pressures [6]. Another option to prescribe BC’s is to 
couple flow rate and pressure in the numerical domain through a 0D model which “lumps” 
vasculature also knows as Lumped Parameter Method [3,4]. By means of adaptive Runge-Kutta 
solver (RK – 4) the system can be tuned and implicitly solved to provide optimized inlet and 
outlet conditions to match patient specific measurements. A no-slip condition is applied at the 
boundary wall to ensure a characteristic viscous flow to ensure a zero velocity profile at lateral 
walls [3,4]. 
1.3.3 FSI Coupled with CFD 
 
Traditional research in cardiovascular mechanics employed models, which were 
idealized, rigid and incompressible. Arterial blood flow in particular has been described by 
incompressible Navier – Stokes equations in a fixed Eulerian frame of reference and the fluid as 
Newtonian [3,4,6]. Advances in computational efficiency allow improving inconsistencies by 
including more realistic flow conditions that account for pressure and velocity variations induced 
by motions of vascular structures.  
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This non – rigid structure can be characterized by a Lagrangian frame of reference and is 
the object of study in the field of Fluid Structure Interaction (FSI). A well-known technique to 
describe FSI is the Arbitrary Lagrangian – Eulerian formulation (ALE) where the Navier – 
Stokes equations (Equation 4) of a moving domain are solved with respect to the elastodynamics 
equations (Equation 5) of the vascular structure which update the computational grid. Kinematic 
and dynamics compatibility conditions control the process. This method accurately captures 
interactions between fluid and solid. It can incur time-consuming computations [4], however. 
 ∇?⃗?𝑥 ⋅ ?⃗?𝑣 = 0 (3) 
 
𝜌𝜌
𝜕𝜕?⃗?𝑣
𝜕𝜕𝜕𝜕
|𝑥𝑥𝑜𝑜 + ∇?⃗?𝑥 ⋅ �𝜌𝜌?⃗?𝑣⨂(?⃗?𝑣 − 𝑣𝑣𝐺𝐺����⃗ )� = ∇?⃗?𝑥 ⋅ 𝜎𝜎 + 𝑓𝑓 (4) 
 
𝜌𝜌𝑜𝑜
𝜕𝜕?⃗?𝑣
𝜕𝜕𝜕𝜕
+ ∇𝑜𝑜 ⋅ (𝜎𝜎𝐸𝐸−𝑇𝑇) = 𝑓𝑓𝑜𝑜���⃗  (5) 
An alternative to the ALE approach is the Coupled Momentum Method (CMM), which 
assumes small wall deformation eliminating grid updating. Fluid – structure interaction is 
enforced by a node – to – node compatibility between the fluid and the wall modeled as a simple 
membrane. This modification lumps elastodynamic equations and fluid dynamics equation 
together reducing the degrees of freedom of the problem. CMM is computationally less intensive 
and retains greater accuracy under the assumption of small deformations [3,4]. 
1.3.4 Lagrangian Method to Track Microscopic Particulate Flow 
 
Blood is not a monophasic fluid; in fact it presents a complex multiphase combination of 
cellular elements and plasma – water solution [5]. An interesting case of particulate is the blood 
clots that can cause stroke. An incompressible fluid whose properties are averages of clinical 
measurements typically approximates the liquid phase. Physical properties of the cellular 
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components can undergo changes due to FSI, hence, these microstructures can deform due to 
flow and flow is affected by the presence of these particles. This duality cannot be overlooked 
when accurately reproducing a patient’s hemodynamics. 
A CFD simulation alone is insufficient to model particle – fluid interaction which 
requires a separate approach. Basic components of thrombi are small enough to be represented 
by reactive particles whose structures are not important. Such particles can be modeled by the 
Discrete Element Method (DEM), which disregards fluid – solid interactions [5]. 
Using this model, thrombogenesis and thrombus transportation can be simulated in the 
form of mechanical interactions between flow and particles allowing the study of VAD 
implantations. While running a simulation is then possible tracking particles released in the 
domain, compute residence time and particle velocities, which can determine the validity of an 
implant for a patient specific geometry. 
1.4 Applications 
 
Combining CFD analysis with FSI to accurately model the fluid domain it is possible to 
match flow conditions found in patients. Adding DEM allows improving the model further 
including effect of particulate in blood. Such a realistic model applied to patient specific 
geometries can have vast medical applications in preventive medicine and surgery [4]. 
Specifically, in the case of LVAD implants, it is possible to potentially select the most 
appropriate implementation configuration. Considering that VAD became a destination therapy, 
device longevity is crucial. Given modern computing power and the numerical model described 
there is room for device design optimization. In depth study of fluid structure interaction and 
improvements in numerical computing methods various types of models such as CFD; FSI and 
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DEM can be implemented in a comprehensive procedure which accurately describe 
hemodynamics. 
In addition, progress in medical imaging techniques such as MRI and CT scan allow 
performing in – vivo material characterization and in – vivo fluid and solid BC which directly 
feed data to the numerical model, greatly reducing the error margin. 
Predictive medicine through numerical model results promising and far – reaching with 
plenty of future work to be done to further reduce inconsistencies such as the incompressible 
flow approximation and the Newtonian – fluid approximation.  
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2 CHAPTER 2: PROBLEM SET UP 
 
As a whole the problem set-up is meant to be divided in mainly two parts. The LPM 
section where given some initial conditions, the model solves a system of differential equations 
producing BC’s that then are fed to CFD that in turn solves the problem for the aortic channel in 
the fluid domain to return both IC and corrected systemic values for the LPM. This loop is 
required as an intermediate step in order to obtain a fully converged flow field in the aortic 
model, which can be used for thrombi Lagrangian tracking. Thrombi-embolism predictions can 
than be carried out by statistical methods over several heart cycles to obtain realistic data. 
The conditions under which the model is set to run are for a patient at rest with mild to 
severe heart failure. Of interest are the flow conditions caused by the LVAD implementation that 
drastically change flow patterns in the aortic channel. As a consequence thrombi travelling 
through this section may behave differently. The main point of this research is to capture this 
phenomenon and establish a predictive model. 
At rest the HR in average is of about 65 BPM (beats per minute). To simulate different 
acuteness of heart failure, a ratio of LVAD-AO (ascending aorta) flow rate in L/min is 
implemented. A mild-to-severe heart failure can be modeled as the heart provides partial support 
to the LVAD. A ratio of 4-1 (VAD to aortic outflow) is taken as a representative value of such a 
case. 
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Table 1 - Model operational parameters. 
Physiological parameter Value 
Heart rate 65 [bpm] 
LVAD-AO flow ratio 
Severe HF 4-1 [L min-1] 
 
2.1 Lumped Parameter Model 
 
The circuit model intends to model the circulatory system based on compliance, flow 
momentum and vaso-resistance, which give an acceptable approximation. In essence the initial 
3-D problem of modeling the total circulation can be reduced to a 50 degree of freedom (DOF) 
0-D problem. This model can be advantageous since it can be adapted to any patient specific 
geometry, given physiological data, free of expenses and can be run several times without any 
issues. In addition analogies between fluid mechanics and electronics allow manipulating and 
solving equations to obtain realistic results for comparison. 
In fluid mechanics, there are several quantities of interest; the two main ones are usually 
pressure and mass or volume flow rate, which allow (once obtained) deriving any other relevant 
result. Pressure in the study of fluid represents a potential that in electronic terms is defined by 
the voltage, similarly the amount of fluid per unit time, which is caused by a potential, can be 
represented by the current defined as the amount of charge per unit time. 
If we were to observe a simple duct, we would notice that the ducts are able to stretch in 
both axial and transversal direction, this is generally defined as vaso-compliance. Compliance 
limits the amount of fluid that a duct can contain. Capacitors in electronics are devices capable of 
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storing charge, then represent a potential for current flow. Hence when modeling compliance we 
use a capacitor in the electronic counterpart. 
In fluid mechanics, duct geometry and wall friction affects the flow, which in turn 
controls the pressures in the channel. Similarly resistors affect the flow of charges in a circuit by 
reducing the potential and obstructing charges, therefore resistors are used to model this physical 
phenomenon. When a fluid passes through a duct its own inertia prevents it from rapid changes 
in its momentum, for both magnitude and direction. This particular property of matter can be 
represented by an inductor which in practice is just a coiled wire, when circulated by a current 
generates a magnetic field that opposes the flow of current. 
Based on the hydraulic analogy it is now possible to design a circuit model, which 
reproduces the circulatory system. We can combine compliance, resistance and inertia effects 
altogether using separate components. Keep in mind that in reality all these flow aspects occur 
simultaneously and not in succession as represented by a circuit.  
 
Figure 5 - Basic circulatory circuit element. 
Following the Greenfield-Fry approach [1], the entire circulatory system can be modeled 
starting from one simple schematic shown above in Figure 5. In some cases either capacitors or 
inductors are omitted in order to simplify the model and reduce computational times, since a tube 
(for example small veins or capillaries) can be too small to account for compliance and inertia 
effects can be ignored for small systems (other forces are more influential). It must be noted 
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however that resistors can never be omitted as it accounts for the geometrical aspects of the 
model and friction losses, which must be considered at any scale. 
As mentioned before the capacitor represents compliance, the inductor inertia and the 
resistor geometrical induced drag. In the schematic provided above, the set up works in the 
following manner: 
1. At node 1, current comes in if it would be going directly towards node 2 it would 
encounter resistance hence it charges the capacitor first (generating a 
voltage/pressure potential); 
2. Once the capacitor if fully charged the discharge begins, current flows from node 
one to node2; 
3. At the resistor we have a drop in voltage (pressure); 
4. At the inductor the voltage drops once more due to change of current over time; 
5. The total change in pressure can be calculated between node 1 and 2. Refer to 
section 6 for evaluations. 
In essence, all the work done by the capacitor is counteracted by the combined efforts of 
resistor and inductor. 
2.2 Circulatory System Model 
 
Starting from the basic circuit model for any vascular vessel, it is now possible to 
generate the circulatory system in succession following the outlined steps. This is carried out for 
the left and right heart, pulmonary system, the aortic channel (region of interest), the arterial and 
venous beds and the cardiac pump. As mentioned earlier, in total this model accounts for a 
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system of the size a 50 DOF, which mainly focuses on the aortic section of the cardiovascular 
circulation. 
2.2.1 Step 1: Left Heart 
 
The heart in general is composed of 2 atria, 2 ventricles and 2 valves that deliver 
oxygenated blood to the rest of the upper and lower parts of the organism and receive 
deoxygenated blood that is supplied to the lungs for re-oxygenation. 
Since the heart is a specialized organ, this reflects on its electronic counterpart. To mimic 
the pumping function of the ventricle (contraction and relaxation), which characterizes a variable 
compliance, the capacitor in our model has to be time dependent as well. Hence a time variable 
capacitor is introduced which follows the inverse of an elastance function to reproduce the heart 
rate (Equation 1). A time dependent component is obtained from curve fitting data as 
 
𝐸𝐸𝑛𝑛(𝜕𝜕𝑛𝑛) = 1.55 ∙ � � 𝜕𝜕𝑛𝑛0.7�1.91 + � 𝜕𝜕𝑛𝑛0.7�1.9� ∙ � 11 + � 𝜕𝜕𝑛𝑛1.17�21.9� (6) 
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Figure 6 - Elastance function waveform. 
 This elastance function abides the following relation: 
 
𝐸𝐸(𝜕𝜕) = 𝐿𝐿𝑆𝑆𝐿𝐿(𝜕𝜕)
𝐿𝐿𝑆𝑆𝑆𝑆(𝜕𝜕) − 𝑆𝑆0 (7) 
where, LVP(t) stands for left ventricular pressure, LVV(t) left ventricular volume and V0 is some 
reference volume at zero ventricular pressure. Referencing to the work by G. Faragallah (et. al), 
the elastance function that drives the circuit is then obtained by: 
 𝐸𝐸(𝜕𝜕) = (𝐸𝐸𝑚𝑚𝑚𝑚𝑥𝑥 − 𝐸𝐸𝑚𝑚𝑚𝑚𝑛𝑛) ∙ 𝐸𝐸𝑛𝑛(𝜕𝜕𝑛𝑛) + 𝐸𝐸𝑚𝑚𝑚𝑚𝑛𝑛 (8) 
where, Emax and Emin are values referring to the end-systolic pressure volume and end-diastolic 
pressure volume relationships. In physiological observation, it is observed that the heart rate 
(HR) is tightly related to the cardiac cycle, in fact the in the expression for the elastance in 
Equation 2, the time variable tn is defined as: 
 
𝜕𝜕𝑛𝑛 = 𝜕𝜕𝑇𝑇𝑚𝑚𝑚𝑚𝑥𝑥 (9) 
Where, tn is the time normalized by a time constant Tmax related to the HR as follows: 
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 𝑇𝑇𝑚𝑚𝑚𝑚𝑥𝑥 = 0.2 + 0.15 ∙ 𝜕𝜕𝑐𝑐 (10) 
 
𝜕𝜕𝑐𝑐 = 60𝐻𝐻𝐻𝐻 (11) 
In addition, to ensure that the flow in unidirectional, two diodes are added in order to model the 
effective control of the flow by the heart valves.  
 
Figure 7 - Heart circuit scheme. 
 
Table 2 - Left heart parameters. 
Parameter Value Physiological meaning 
Resistance [mmHg s mL-1] 
Rla 8.90 10-5 Left atrial resistance 
Rlv 1.78 10-5 Left ventricular resistance 
Compliance [mL mmHg-1] 
cla 13.33 Left atrial compliance 
clv(t) Reciprocal of Elv(t) Left ventricular compliance 
Elastance constants 
Emin [mmHg mL-1] 0.049 Diastolic pressure-volume relationship 
Emax [mmHg mL-1] 2.49 Systolic pressure-volume relationship 
Tmax [s] 0.338 Normalized time 
 
 
 17 
2.2.2 Step 2: CFD 
 
Throughout the aortic channel, following Figure 8, the model outlined in section 3.1 is 
repeatedly used to model each subdivision of the region. To maintain the outmost accuracy, 
compliance, resistance and inductance are kept for the largest vessels in the model. Compliances 
and inductances however will have static values obtained from physiological data. Resistances 
on the other hand attain invariance once the flow field is converged. 
 
Figure 8 - CFD circuit scheme. 
Hence as briefly outlined at the beginning section 3, the loop alternating LPM and the 
CFD simulation will provide accurate values for these resistances which will allow to proceed to 
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the particle tracking. In the following table, the resistance values of the tuned model to initiate 
the iterative process have been listed. 
Table 3 - CFD domain resistance parameters [mmHg s mL-1] for 4-1 LVAD-AO flow ratios. 
Parameters 4-1 Values Physiological meaning 
Rao 0.1147 Ascending aorta resistance 
Rrc 1.42 Right coronary resistance 
Rlc 0.964 Left coronary resistance 
Ria_cor 0.0054 Innominate to coronary resistance  
Rcan 0.0677 Cannula resistance 
Ria_vad 0.002 Innominate to cannula resistance 
Ria_rca 0.0198 Right carotid to innominate resistance 
Rrca 0.23 Right carotid resistance 
Ria_rsa 0.06 Right subclavian to innominate resistance 
Rrsa 0.176 Right subclavian resistance 
Rrver 0.939 Right vertebral resistance 
Rlca_ia 0.00381 Left carotid to innominate resistance 
Rlca 0.272 Left carotid resistance 
Rlsa_lca 0.0051 Left subclavian to left carotid resistance 
Rda_lsa 0.13 Descending aorta to left subcalvian 
resistance 
Rlsa 0.497 Left subclavian resistance 
Rlver 1.65 Left vertebral resistance 
Rda 0.006 Descending aorta resistance 
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2.2.3 Step 3: Arterial and Venus Beds 
 
Once done with the CFD section, it is necessary to add arterial and venous beds at each 
outlet. Since the part of interest is the CFD section (in our case the aortic arch), the rest of the 
system can be simply treated as a stack of arties, which bring oxygenated blood to the organs, 
and veins that carry the oxygen-poor blood back to the lungs. This part can then be simplified by 
two different versions of Figure 5. To model arterial beds, we utilize the complete circuit model. 
While for veins, since the amount of fluid is greatly reduced, for our purposes inertial effects can 
be neglected, we omit the inductor. Figure 9 has the circuit schematic. 
 
Figure 9 - Arterial and venous beds circuit scheme. 
The vascular model can be simplified if desired to reduce the amount of variables to 
monitor. To achieve this, each outlet maintains its own arterial bed while for paired vessels such 
as subclavians, carotids, vertebrals and coronaries the venous beds are combined. Each outlet can 
then be connected to a common node (joint node), which leads to the right heart section, closing 
the loop. In general this approximates the summation of upper and lower body venous flows that 
converge to the heart. 
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Table 4 - Parameters of arterial and venous beds at CFD outlets for 4-1 LVAD-AO flow ratio. 
Parameter 4-1 Values Physiological meaning 
Rrcora Rrcora(t)a Right carotid arterial resistance 
Rlcora Rlcora(t)a Left carotid arterial resistance 
Rcorvb 12.987 Coronary venous bed resistance 
Rrsb 3.679 Right subclavian arterial resistance 
Rlsb 3.679 Left subclavian arterial resistance 
Rdsb 4.599 Subclavian venous bed resistance 
Rrcb 3.318 Right carotid arterial resistance 
Rlcb 3.318 Left carotid arterial resistance 
Rdcb 4.313 Carotid venous bed resistance 
Rrvb 10.588 Right vertebral arterial resistance 
Rlvb 9.86 Left vertebral arterial resistance 
Rdvb 31.233 Vertebral venous bed resistance 
Rda_b 1.838 Descending aorta resistance 
Rivb 4.596 Lower body venous bed resistance 
Compliance [mL mmHg-1]   
crcora 0.01 Right carotid arterial compliance 
clcora 0.01 Left carotid arterial compliance 
ccorvb 0.19 Coronary venous bed compliance 
crsb 0.193 Right subclavian arterial 
compliance 
clsb 0.193 Left subclavian arterial 
compliance 
cdsb 0.097 Subclavian venous bed 
compliance 
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Parameter 4-1 Values Physiological meaning 
crcb 0.193 Right carotid arterial compliance 
clcb 0.2 Left carotid arterial compliance 
cdcb 0.1 Carotid venous bed compliance 
crvb 0.029 Right vertebral arterial compliance 
clvb 0.029 Left vertebral arterial compliance 
cdvb 0.015 Vertebral venous bed compliance 
cda_b 54.3 Descending aorta compliance 
civb 27.15 Lower body venous bed 
compliance 
Inductor [mmHg s2 mL-1]   
Lrsb 0.0214 Right subclavian arterial 
inductance 
Llsb 0.0214 Left subclavian arterial inductance 
Lrcb 0.0214 Right carotid arterial inductance 
Llcb 0.0214 Left carotid arterial inductance 
Lrvb 0.0107 Right vertebral arterial inductance 
Llvb 0.0107 Left vertebral arterial inductance 
Lda_b 0.0005 Descending aorta inductance 
a Refer to Equation 12 for the time dependent coronary arterial resistance function 
The coronary arteries represent an exception in the system. From a physiological 
perspective coronaries are the vessels that carry oxygenated blood to the myocardium. On the 
other hand vessels that remove the deoxygenated blood from the heart are known as cardiac 
veins. During systole (contraction) the coronary arteries are compressed due to high ventricular 
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pressures, which prevents blood flow; most of the perfusion occurs in the diastolic phase 
(relaxation). 
 
Figure 10 - 180° out of phase waveforms. 
Hence to model this phenomenon the coronary circulation has to be out-of-phase as 
shown in Figure 10. A simple expression based on the elastance function allows us to offset the 
coronary arterial vascular beds and adjust the magnitude of the waveform: 
 
𝐻𝐻𝑐𝑐𝑜𝑜𝑐𝑐𝑚𝑚(𝜕𝜕) = �1.75 ∙ ��𝐸𝐸𝑙𝑙𝑙𝑙(𝜕𝜕)𝐸𝐸𝑙𝑙𝑙𝑙(0)��2 + 6.796� ∙ 𝐻𝐻𝑓𝑓𝑚𝑚𝑐𝑐𝑓𝑓_𝑐𝑐𝑜𝑜𝑐𝑐 (12) 
where Rfact_cor is a scaling factor allows the user to tune the model. The venous bed is then 
modeled following the venous section of Figure 8. Resistance and compliance are listed in Table 
4. 
2.2.4 Step 4: Right Heart 
 
The right heart section can be handled in a similar fashion to the left heart, refer to 
section 2.2.1. Distinctions are made in terms of compliance, resistance and inductance, all 
dictated by physiological observation. In short, the left heart is due to provide enough pressure to 
satisfy the required blood supply in the upper and lower body, while the right heart is due to 
power circulation in the pulmonary system. Hence in magnitude, left heart compliance is greater. 
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To mimic such an observation, the elastance function expression presented earlier has its Emax 
and Emin values changed, updated values are found in the following table. 
Table 5 - Right heart parameters. 
Parameter Value Physiological meaning 
Resistance [mmHg s mL-1] 
Rra 5.94 10-5 Right atrial resistance 
Rrv 1.19 10-5 Right ventricular resistance 
Compliance [mL mmHg-1] 
cra 16.67 Right atrial compliance 
crv(t) Reciprocal of Erv(t) Right ventricular compliance 
Elastance constants 
Emin [mmHg mL-1] 0.0243 Diastolic pressure-volume relationship 
Emax [mmHg mL-1] 0.523 Systolic pressure-volume relationship 
Tmax [s] 0.338 Normalized time 
 
2.2.5 Step 5: Pulmonary System 
 
Keep in mind that physiologically, the lungs produce very little resistance to the blood 
flow since they oxygenate the blood. Due to this lungs have also little compliance. Hence when 
tuning the model one should understand that the parameters for the resistor and the capacitor will 
be kept smaller than other systemic parameters. 
The pulmonary beds are an exception to all others. Physiologically the pulmonary 
circulatory system is reversed as the pulmonary artery carries hypoxic blood and the pulmonary 
vein carries oxygen rich blood. Geometrically, these pulmonary veins are larger than any other 
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veins; therefore inertial effects cannot be entirely neglected. Hence unlike section 3.3 the 
inductor in the venous bed circuit is not omitted.  
Note however that even though inductors in each basic circuit model are considered when 
it comes to their actual magnitude, they are basically unaccounted for. They only affect the 
systems in a small part since the values are several orders of magnitude smaller than resistors and 
capacitors. 
2.2.6 Step 6: LVAD 
 
A model for the LVAD was implemented following the work of G. Faragallah (et al.) 
where the combination of the LVAD pump circuit and the cardiovascular system circuit resulted 
in a 6th order circuit (Figure 19). In essence, the left heart is modeled in detail, following the 
CRL scheme. A general compliance, resistance and inductance approximate the aortic channel. 
A total resistance Rs then represents the rest of the systemic structure, which sums up the 
resistance offered by the arterial and venous beds. The only variable present in this particular 
model is the systemic resistance that can be estimated in terms of the LVAD pump flow, based 
on the observation that at rest the systemic resistance tends to be high and low when active. 
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 Figure 11 - Closed loop circuit for LVAD implementation, G. Fargallah et. Al [8]. 
The pump is implemented into the circulatory system in parallel between the left 
ventricle and the initial node of the aorta as in Figure 11. The drop in pressure across the VAD is 
expressed by the equation derived by authors as: 
 
𝐿𝐿𝑆𝑆𝐿𝐿(𝜕𝜕) − 𝐴𝐴𝐴𝐴𝐿𝐿(𝜕𝜕) = 𝐻𝐻∗𝑄𝑄 + 𝐿𝐿 𝑑𝑑𝑄𝑄
𝑑𝑑𝜕𝜕
− 𝛾𝛾
𝑖𝑖(𝜕𝜕)
𝑄𝑄
 (13) 
From this equation, the most important parameter that allows the user to regulate the 
VAD flow rate is i(t), which represents the amount of current supplied to the pump. Hence by 
calibrating this unique constant flow conditions between ascending aorta and cannula inlet can 
be established. 
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Table 6 - Cardio vascular model parameters in the Faragallah et al. [8] model. 
Parameters Values Physiological meaning 
Resistance [mmHg s mL-1] 
RS 1.00 Systemic vascular resistance 
RM 0.005 Mitral valve resistance 
RA 0.001 Aortic valve resistance 
RC 0.0398 Characteristic resistance 
Compliance [mL mmHg-1] 
C(t) Reciprocal of Elv(t) Left ventricular compliance 
CR 4.40 Left atrial compliance 
CA 0.08 Aortic compliance 
CS 1.33 Systemic compliance 
Inductance [mmHg s2 mL-1] 
LS 0.0005 Inertia in blood in aorta 
 
Table 7 - LVAD parameters in the Faragallah et al. [8] model. 
Parameters Value Physiological meaning 
Cannula resistance [mmHg s mL-1] 
Ri 0.0677 Inlet cannula resistance 
Rp 0.1707 Pump resistance 
Ro 0.0677 Outlet cannula resistance 
Cannula inductance [mmHg s2 mL-1] 
Li 0.0127 Inlet cannula inductance 
Lp 0.02177 Pump inductance 
Lo 0.0127 Outlet cannula inductance 
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Table 8 - Variable in cardio vascular model. 
Variable Name Physiological meaning (units) 
x1(t) LVP(t) Left ventricular pressure [mmHg] 
x2(t) LAP(t) Left atrial pressure [mmHg] 
x3(t) AP(t) Arterial pressure [mmHg] 
x4(t) AoP(t) Aortic pressure [mmHg] 
x5(t) QT(t) Total flow [mL s-1] 
x6(t) QP(t) Pump flow [mL s-1] 
 
In our model, in order to attain the prescribed flow rates found in Table 1 the input 
current to the VAD was modified. For the 4-1-flow ratio case, this value was set to be 0.03825. 
Small adjustments are then performed to the global scaling factor to have a matching ventricular 
waveform with physiological data.  
2.2.7 Model Tuning 
In order to facilitate the process of tuning the model factors have been implemented to 
modify parameters such as compliances and resistances in bulk saving the user time. In principle 
the user must first set capacitance values according to parameters found in literature or through 
calculations based on physiological date for pressure and flow rates using Equation (24). Once 
these values have been established inductances can be set to relatively low values initially and 
finally resistance values can be added in a similar fashion as for capacitance. 
By means of the tuning parameters it is now possible to refine the model. Capacitance 
can be tuned to reach physiological waveforms that lie within a reasonable range as it 
manipulates vaso-compliance.  As the waveforms appear to lie in the same order of magnitude as 
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a patient’s then the model can be finely tuned to replicate the physiological waveforms found in 
literature. Inductance provides an extra refinement tuning parameter once the model finalized. 
2.3 Generating System of Differential Equations 
 
To solve the given circuit, it is necessary to recall the analogy that can be made between 
electrical concepts and fluid concepts. In the following schematic there are represented all the 
equations. 
 
Figure 12 - Hydraulic analogy. 
By means of Kirchhoff’s node and loop laws which state that the sum of all currents 
entering and leaving the node has to be equal to zero and that the sum of all voltages in a loop 
has to be zero as well, it is possible to obtain the required differential equations. Performing this 
equilibrium equation at every node of the closed circulatory system we obtain a set of differential 
equations, which can be the solved using an adaptive Runge-Kutta, for voltages and currents. 
These results can then be converted to actual fluid parameters such as pressure and mass/volume 
flow output. 
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For consistency in the code, both voltage and current have been labeled a state variable 
‘y’. It is important to distinguish the difference between y-voltages and y-currents. In general, 
every ‘y’ at a node refers to a voltage while every ‘y’ accompanied by an arrows alludes to a 
current. It can be very helpful when deriving the equations, to couple your work with an 
extensive schematic in order to keep track. 
• Node Law: 
1. We can start from the concept stated earlier:  
 �𝐼𝐼 = 0 (14) 
2. Referring to Figure 8 and Figure 7 (node yi+2) one can perform the current 
equilibrium at the node as follows. 
 𝐼𝐼𝑚𝑚𝑛𝑛 + 𝐼𝐼𝐶𝐶 = 𝐼𝐼𝑜𝑜𝑜𝑜𝑓𝑓 (15) 
Which can then be written in a more extensive form. 
 
𝑦𝑦𝑚𝑚+1 + 𝐶𝐶 𝑑𝑑𝑦𝑦𝑚𝑚+2𝑑𝑑𝜕𝜕 = 𝑦𝑦𝑚𝑚+2 − 𝑦𝑦𝑚𝑚+3𝐻𝐻  (16) 
That can be rewritten in terms of the derivative  
 
?̇?𝑦𝑚𝑚+2 = 1𝐶𝐶 (𝐼𝐼𝑜𝑜𝑜𝑜𝑓𝑓 − 𝐼𝐼𝑚𝑚𝑛𝑛) → 𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 (17) 
• Loop Law: 
1. In this case the key idea is the following 
 �𝑆𝑆 = 0 (18) 
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2. In general for each elementary circuit loop in Figure 5 the previous expression 
can be then modified as 
 𝐶𝐶𝑉𝑉 + 𝐻𝐻𝑉𝑉 + 𝐼𝐼𝑉𝑉 = 0 (19) 
Or 
 
𝐿𝐿
𝑑𝑑𝑦𝑦𝑚𝑚+1
𝑑𝑑𝜕𝜕
= 𝑦𝑦𝑚𝑚 − 𝐻𝐻𝑦𝑦𝑚𝑚+1 − 𝑦𝑦𝑚𝑚+2 (20) 
Now we need to isolate the differential variable 
 
?̇?𝑦𝑚𝑚+1 = 1𝐿𝐿 (𝑦𝑦𝑚𝑚 − 𝐻𝐻𝑦𝑦𝑚𝑚+1 − 𝑦𝑦𝑚𝑚+2) → 𝐸𝐸𝐹𝐹𝐴𝐴𝐹𝐹 (21) 
Using equations 1 and 2 that were just derived in a general form, modifying the 
subscripts appropriately one should be able to obtain a system of differential equations that can 
be solved using a 4th order adaptive Runge-Kutta method. 
To avoid any closure problems, at each node in the model, reference voltage are 
prescribed in order to obtained a closed formed system which can be readily solver by a number 
of numerical methods. Reference voltage are expressed as follows: 
 
𝑆𝑆𝑐𝑐𝑟𝑟𝑓𝑓𝑖𝑖 = 𝑦𝑦 𝑙𝑙𝑜𝑜𝑙𝑙𝑓𝑓𝑚𝑚𝑣𝑣𝑟𝑟
𝑏𝑏𝑟𝑟𝑓𝑓𝑜𝑜𝑐𝑐𝑟𝑟 𝑛𝑛𝑜𝑜𝑛𝑛𝑟𝑟 − ��𝑦𝑦 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑟𝑟𝑛𝑛𝑓𝑓𝑠𝑠𝑙𝑙𝑟𝑟𝑚𝑚𝑙𝑙𝑚𝑚𝑛𝑛𝑣𝑣 𝑛𝑛𝑜𝑜𝑛𝑛𝑟𝑟� ∙ 𝐻𝐻𝑏𝑏𝑟𝑟𝑓𝑓𝑜𝑜𝑐𝑐𝑟𝑟𝑛𝑛𝑜𝑜𝑛𝑛𝑟𝑟  (22) 
In addition to further simplify the system and reduce the algebraic load, expression for 
the currents are introduced. In Figure 13 there is a full representation of the LPM circuit 
excluding the LVAD circuit found in section 2.2.6, in the appendix there is an alternative 
representation that includes the LVAD portion of the circuit. The full set of differential equations 
can be found in the appendix in the form of a Mathcad spreadsheet snap shots. 
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 Figure 13 - LVAD circuit LPM. 
2.4 Solver 
 
Initially the LPM was designed in Mathcad for simplicity, once the model was validated, 
it was translated into a much faster version in C++ programming language. In essence, the 
method implemented to solve the system of ordinary differential equations (ODEs), is an in 
house adaptive 4th order Runge-Kutta (RK-4). Given a set of initial condition for pressure and 
flow rates, an absolute error tolerance, an initial number of steps and the system of ODEs, the 
solver provides an output for however many heart cycle the user requires. This output represents 
the time-dependent BCs, required in the unsteady CFD model.  Reference to the appendix for the 
full code. 
A total of 11 time-varying BCs are generated which provide a waveform that drives the 
CFD solution to a settled flow field. As a validation procedure, the output waveform for the 
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ventricular pressure and aortic pressure are sampled in order to compare them to physiological 
data. In addition, LVAD-AO (ascending aorta) flow rates are monitored to ensure the prescribed 
flow ratios are maintained. 
2.5 CFD Simulation 
2.5.1 Fluid Domain 
 
The 3D computation fluid dynamics model is solved using StarCCM++ CFD code. The 
fluid domain is dictated by a geometry specific aortic channel provided by a patient CT scans 
(Figure 14), accordingly modified to fit the cannula of the assist device. The mesh was generated 
using PointWise.  
 
 
Figure 14 – Patient-specific geometries with LVAD configurations. 
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The walls of the model are considered rigid to reduce the number of degrees of freedom 
and simplify the system. However previous work carried out by Osorio et al. [1] in which the 
same problem was solved for steady state conditions, proved to output realistic solution. 
The Eulerian-Lagrangian modeling used has the particles modeled by the Lagrangian 
scheme and the continuous phase modeled by the Eulerian method. In the simulation blood is 
modeled as a Newtonian incompressible fluid with density 1060𝐾𝐾𝑣𝑣
𝑚𝑚3
 and dynamic viscosity of 
0.004𝑁𝑁𝑠𝑠
𝑚𝑚2
. Transient flow was modeled having 1 𝑙𝑙
𝑚𝑚𝑚𝑚𝑛𝑛
 emanating from the aortic root and 4 𝑙𝑙
𝑚𝑚𝑚𝑚𝑛𝑛
 from 
the LVAD. As previously mentioned, time-dependent BCs provided by the LPM in terms of 
pressures and flows are set at 2 inlets and 9 outlets in the form of tabulated files. 
Once the BC’s are correctly assigned, the model is set up following a necessary scheme 
based on the required time step and number of inner iterations. Initially to have an initialized 
flow field based on the BCs, the solver runs for 250 inner iteration. First freezing the time and 
letting the solver run until the residuals no longer varied determined this. As the initial flow is 
set, number of inner iterations is decreased to either 200 or lesser iterations, just enough to obtain 
accurately converged outputs. 
The necessary feedback to evaluate the new set of systemic resistances for the aortic 
channel are obtained by setting cross sectional plane monitors at each location representing a 
node found in the 0D model. 
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 Figure 15 - Monitor crossection in CFD domain (left) and a close up of the upper aortic arch (right). 
The solver is set to run until the physical time is reached. At this point tabulated values 
for each cross-section are outputted. Once flow and pressure values are collected and time 
averaged it is possible to calculate resistance by 
 
𝐻𝐻 = 𝐿𝐿𝑚𝑚 − 𝐿𝐿𝑚𝑚+1
?̇?𝑚𝑚𝑚
 (23) 
To evaluate compliance and inductance the following expression can be useful in case it 
may be necessary to check values measured from the simulation and compare them to the 
parameters in the LPM. 
 
𝐶𝐶 = ?̇?𝑚𝑚𝑚 ∙ Δ𝜕𝜕
𝐿𝐿𝑚𝑚 − 𝐿𝐿𝑚𝑚+1
 (24) 
 
𝐿𝐿 = 𝐿𝐿𝑚𝑚 ∙ Δ𝜕𝜕
?̇?𝑚𝑚𝑚 − ?̇?𝑚𝑚𝑚+1
 (25) 
The fluid is modeled to be blood, hence the default properties of water in StarCCM were 
changed to fit blood specifications. 
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2.5.2 Particles 
The Lagrangian tracking model entails solid spherical non-interacting particles modeled 
as point masses of set diameter of either 2.5mm or 3.5mm, which are released at the bottom 
portion of the cannula by an injection grid (Figure 16). The release randomness has been set to 
have 2 degrees of randomness in time and one degree of spatial randomness. 
Spatial randomness is dictated by a point inclusion probability that determines how many 
nodes in the grid will be injecting a particle at each time step. Randomness is time is introduced 
by generating a time-dependent particle release table. By means of a random number generating 
function in Excel with values bounded by 0 and 1 and an imposed time-step about 6 times 
smaller than the simulation time-step. At a randomized time step, the simulation releases a 
constant number of particles at random nodes of the grid, one or none per time-step. This ensures 
realistic statistical variance in the data collected. 
 
Figure 16 - Injection grid at the base of the inlet cannula. 
The specific Excel function used to produce random number was expressed as follows: 
 = 𝑃𝑃𝑟𝑟𝑟𝑟𝑑𝑑𝑟𝑟𝑃𝑃𝜕𝜕𝐹𝐹𝑃𝑃𝑃𝑃𝑟𝑟(0,1) (26) 
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In order to have means of comparison with previous work [1-2] the particulate phase has a 
constant density of 1116.73 𝐾𝐾𝑣𝑣
𝑚𝑚3
 and interactions have been defined in for wall-to-particle 
interaction as having friction and fully elastic collisions. 
 
Figure 17 - Particle injection at LVAD inlet. 
As the model injects particles in the domain (Figure 17), they can be tracked throughout 
the model using built in track files, which allow the user to count detect particles at different 
outlets defined by specific boundaries. Simultaneously real-time plots can be generated to 
quantify the total amount of particles in the domain and the amount of particles leaving or 
entering the CFD domain at each boundary. These plots can then be tabulated and used for 
statistical analysis. 
2.6 Coupling 
 
As mentioned earlier, before initiating the Lagrangian particle tracking it is imperative 
for the flow domain to be converged. Hence the LPM and the CFD simulation need to be 
coupled over several cycles. In addition, to automate the procedure feeding BC’s to the 
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simulation and have the newly evaluated resistances returned to the solver, an intermediate 
program was added. 
The main tasks of this program are to handle the required tables for each iteration and 
prescribe the number of loops to perform, the number of heart cycles (for both the RK-4 and the 
CFD), number of steps and number of inner cycles to the RK-4 and CFD solvers.  
A schematic of the workflow is provided in Figure 18. 
 
Figure 18 - Coupling loop work flow. 
Once the set-up is completed. The entire system is initiated through STAR-CCM+, the 
Java coupling code is run directly into the simulation, and one iteration is represented by 3 to 5 
heart cycles. A certain amount of cycles are run to have converged flow results. Following the 
user may add however many extra cycles are needed to run particle tracking. A summary of the 
code is provided, in the appendix. 
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2.7 Statistical method 
In this study the statistical analysis was carried out in two steps: first the body of data 
relative to thrombus transport was generated to produce means and standard deviations to show 
consistency throughout runs and compare geometries then the pooled statistics were compared to 
similar solutions carried out with steady state simulations by means comparison. 
Each run produced concise tables of particle transition at every outlet including data 
recording particle injection into the domain. Particle percentages were then computed with the 
following expression: 
 
𝐿𝐿𝑟𝑟𝑃𝑃𝜕𝜕𝑖𝑖𝑃𝑃𝐹𝐹𝑃𝑃% = 𝑟𝑟𝑃𝑃𝑚𝑚𝑟𝑟𝑃𝑃𝑃𝑃 𝐴𝐴𝑓𝑓 𝑝𝑝𝑟𝑟𝑃𝑃𝜕𝜕𝑖𝑖𝑃𝑃𝐹𝐹𝑃𝑃𝑃𝑃 𝑟𝑟𝜕𝜕 𝐴𝐴𝑃𝑃𝜕𝜕𝐹𝐹𝑃𝑃𝜕𝜕
𝑟𝑟𝐴𝐴𝑚𝑚𝑟𝑟𝑃𝑃𝑃𝑃 𝐴𝐴𝑓𝑓 𝑝𝑝𝑟𝑟𝑃𝑃𝜕𝜕𝑖𝑖𝑃𝑃𝐹𝐹𝑃𝑃𝑃𝑃 𝑖𝑖𝑟𝑟𝑖𝑖𝑃𝑃𝑃𝑃𝜕𝜕𝑃𝑃𝑑𝑑 100 (27) 
Once all runs were analyzed, for each particle size and geometry means and standard 
deviation were evaluated for each outlet and specifically cerebral vessels a statistical method 
comparing two means was employed to compare steady state simulation and unsteady 
simulations results to determine whether steady modeling would suffice in order to engage in 
depth studies on stroke incidence. 
The Z-score was calculated based on the probability of a thrombus transitioning through 
carotid and vertebral arteries in the steady and unsteady cases as: 
 𝑍𝑍 = 𝜇𝜇1 − 𝜇𝜇2
�𝑝𝑝 ∙ 𝑞𝑞 �
1
𝑟𝑟1
−
1
𝑟𝑟2
�
 
(28) 
Where 𝜇𝜇1 and 𝜇𝜇2 represent the means of the two populations, 𝑟𝑟1 and 𝑟𝑟2  represent the 
populations sizes, 𝑝𝑝 is the overall probability and 𝑞𝑞 = 1 − 𝑝𝑝. The Z-score is intended to quantify 
the amount of deviation from a mean based on standard deviations; in a normal distribution 68% 
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of a populations resides within a standard deviation, 95% of a population resides within two 
standard deviations and 99.7% of a population resides with three standard deviations. A 
representation of such a distribution in captured in Figure 19. 
 
Figure 19 - Normal distribution bell curve. 
In this study we employ a two-tailed, two means Z-score, which compares values from 
two different populations and determines criteria for comparison. A null hypothesis rests on the 
two populations being very similar, the alternative hypothesis having the two populations being 
different. A Z-score falling within the confidence interval dictated by standard deviation interval 
of choice would lead to the rejection of the alternative hypothesis. 
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3 CHAPTER 3: RESULTS 
 
3.1 LPM Outputs 
As aforementioned the LPM models the cardiovascular system and provides BC the CFD 
code requires to initiate the flow computations. A total of 11 BC are needed to fully define the 
fluid domain as displayed in the following table. 
Table 9 - Definition of BC at each boundary. 
Boundary Definition Quantity 
Ascending Aorta (AO) Stagnation inlet Pressure 
LVAD Mass flow inlet 
Mass flow 
 
Right Coronary (R_Cor) 
Mass flow outlet 
Left Coronary (L_Cor) 
Right Carotid (RCA) 
Left Carotid (LCA) 
Right Subclavian (RSA) 
Left Subclavian (LSA) 
Right Vertebral (R_Vert) 
Left Vertebral L(_Vert) 
Descending aorta (DA)   
 
In order to verify the BCs compare to actual patient measurements waveform at key 
locations have been produced and compared to values found in literature for mild and acute HF 
in vivo. This provides this portion of the study with additional validation considering the DOF 
present in the model. 
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 Figure 20 – In vivo pressure waveforms for left ventricle and aorta by Adam R. Travis et. al [11]. 
 
Figure 21 - Pressure and flow rate waveform generated by LPM. 
Taking the plot in Figure 20 for high LVAD support and comparing to Figures 21 we see 
essentially the same wave patterns.  A large pressure differential caused by acute heart failure 
induced by the LVAD maintaining the homeostatic pressure in the aorta. Pressure magnitudes 
also fit in vivo measurements for both the ventricular pressure and the aortic pressure. Most 
importantly, physiologically coronaries experience blood flow that is out of phase from the 
cardiac cycle: flow occurs during the systolic phase. In each case the coronary waveform plotted 
in Figure 21 displays this trend.  
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These results validate the LPM we designed as our model closely matches in vivo 
measurements and realistically maintains physiological flow patterns. 
3.2 Flow Field Convergence 
For each patient-specific geometry the couple system was ran until a sustained solution 
was reached. The required iteration may differ based on geometrical and flow features. In the 
following sections results for the converged solutions will be provided for each case. 
In order to test for convergence, for each cross-sectional monitor in the flow domain the 
tabular values have been averaged and plotted (a sample will be provided for each model for the 
Ascending Aorta section in Figure 22). Each plot shows the number of iterations required to 
reach a sustained flow field and provide proof of repeatability. 
 
Figure 22 - AO cross-section monitor plane. 
3.2.1 Shift up geometry 
With a mesh of about 3 million elements and due to low turbulence at the jet inlet in the 
aortic channel, this model presented with the fastest iterative rate. One heart cycle can be run in 
about 6 hours, while 3 heart cycles can take up to a day employing a total of 40 CPUs. 
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 Figure 23 - AO averaged mass flow rate per iteration in shifted-up LVAD. 
From the calculations we recognize that at about the 13th iteration the flow field begins to 
settle to a unique solution. Major spikes in the percent change plot are present due to lack of 
inner iteration at particular time-steps, which would have required more, causing the solution to 
deviate. Such deviation were removed by implementing an adaptive iteration criteria that has the 
model move to the next time step only when residuals for x-momentum, y-momentum, z-
momentum, continuity and energy remain steady for several iterations. The plots show the model 
to be very stable once it reaches the settles flow field, and maintains the same field with 
negligible variations. 
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Figure 24 - Streamlines representation through one heart cycle. 
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Figure 25 - Vector flow field representation through one cycle. 
 
Figure 26 - Cardiac cycle. 
Figures 24-25 show flow field representation at key locations through the heart cycle, in 
systole and diastole for a sustained solution. Jet interaction with flow emitted from the aortic root 
are clearly modeled and represented. The cannula jet experiences slight impingement on the 
opposing interior aortic wall. Through a cardiac cycle the jet suffers minor fluctuations due to the 
interaction with the cardiac ejected flow. This phenomenon is to be expected given the pulsatile 
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nature of the flow. At the peak of the cycle this interaction also produces large areas or 
recirculation at the base of the innominate artery, which could potentially cause particle to 
stagnate and embolize to the cerebral vessels. A much smaller degree of recirculation is 
generated by the weak impingement in the aortic root. This could similarly cause embolization in 
the eventuality of a particle transitioning in the region. It is noted that we can observe the out of 
phase flow present in the coronary vascular bed. 
3.2.2 Perpendicular geometry 
In this case the grid converged mesh present about between 1-2 millions cells, and 
increased number of cells in the jet inlet was required due to high recirculation as the jet 
impinges onto the facing aortic wall. One heart cycle can be run in 12 hours and 3 cycles require 
about 2 days and a half when using 60 CPUs. Considering the turbulent phenomena the 
simulation proved to be fast-paced. 
 
Figure 27 - AO averaged mass flow rate per iteration in perpendicular LVAD. 
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Based on the above computations we recognize that at about the 15th iteration the flow 
field begins to settle to a unique solution. Once again major deviations are due to lack of inner 
iteration at particular time-steps, which would have required more, causing the solution to 
deviate. But the loop shows to converge fast right after. Just as for the shift-up geometry the 
perpendicular model demonstrates stability for the settled solution. 
 
 
Figure 28 - Streamlines representation through one heart cycle. 
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Figure 29 - Vector flow field representation though one heart cycle. 
 
Figure 30 - Cardiac cycle. 
As for the intermediate geometry, Figures 26-27 show a sustained flow field solution at 
key locations through the heart cycle, in systole and diastole. Jet interaction with flow emitted 
from the aortic root are clearly modeled and represented. Jet impingement is effectively 
represented in both visualizations. The strong impingement causes stagnant flow and major 
recirculation due to large losses in momentum in the continuous phase. Close inspection shows 
 49 
that we find strong recirculation in the aortic root near the coronary arteries and in the upper 
portion of the aortic arch. This phenomenon can cause thrombi to experience increased residence 
period in sensitive areas at risk of occluding cerebral and cardiac vessels increasing potential 
morbidity due to the VAD implantation. In addition the aforementioned interaction causes 
cannula jet oscillations, which strongly indicate periodic flow patterns not captured in a steady 
state model. Again we can observe the out of phase flow present in the coronary vascular bed. 
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4 CHAPTER 4: DISCUSSION OF PARTICLE TARCKING RESULTS 
Various percentages for particles entering vertebral and carotid vessels are displayed in 
Table 9. In all cases thrombo-embolization tends to mainly occur in the carotid arteries. A more 
detailed summary of all collected data can be found in the Appendix C for each vessel and 
geometry. 
Table 10 - Percentages of particle entering cerebral vessels. 
 
Particle size 
 
Vertebrals Carotids Overall Overall 
Configuration 2.5mm 3.5mm 2.5mm 3.5mm 2.5mm 3.5mm Vertebrals Carotids Total 
Intermediate 3.59±1.52 3.53±1.33 24.98±1.44 25.70±3.19 28.57±1.27 29.23±4.48 3.87±0.57 25.99±1.89 28.81±2.03 
Perpendicular 0.94±0.92 0.78±0.70 8.22±1.53 10.93±2.97 9.16±0.69 11.71±3.02 0.95±0.64 8.99±1.17 10.33±1.33 
 
Embolization rates for cerebral vessels involving particles of size 2.5mm result 
significantly higher for the intermediate geometry in both vertebral and carotid arteries. This 
translates in increased stroke chances directly caused by this specific diameter. A similar fashion 
is observed for particles of 3.5mm diameter. 
Furthermore there seems to be a correlation between stroke rate probability and particle 
size. As particle size increases the embolization rate tend to rise as well. In the carotid vessels 
this occurs more markedly that in vertebral arteries. As aforementioned, the statistical 
comparison of means is obtained imposing a 95% confidence interval, and incurring in the null 
hypothesis when having equal means. The alternative hypothesis yields different means. 
Table 11 - Testing criteria for null hypothesis 𝝁𝝁𝟏𝟏 − 𝝁𝝁𝟐𝟐 = 𝟎𝟎. 
Alternative hypothesis Reject null hypothesis if: 
𝜇𝜇1 − 𝜇𝜇2 ≠ 0 Z > 1.96 or Z < -1.96 
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A Z-score between 1.96 and -1.96 would translate into the rejection of the alternate 
hypothesis and Z-score of 0 would prove equal means. 
Table 12 - Z-score of mean comparison between steady and transient models. 
 
Particle size 
  
Overall 
configuration Mode 2.5 3.5 
 
Vertebrals Carotids total 
Intermediate Unsteady 28.57±1.27 29.23±4.48 
 
3.87±0.57 25.99±1.89 28.81±2.03 
 
Steadya 18.44±0.76 11.11±1.19 11.15±2.36 1.39±1.18 12.17±1.42 13.56±1.59 
Z-score 
 
10.76 23.43 23.35 12.09 24.43 25.76 
Perpendicular Unsteady 9.16±0.69 11.71±3.02 
 
0.95±0.64 8.99±1.17 10.33±1.33 
 
Steadya 21.38±1.71 10.97±1.27 9.31±1.02 1.75±1.33 12.13±0.91 13.89±1.36 
Z-score 
 
-7.69 0.46 1.59 -1.97 -3.10 -3.31 
a Statistical data, means and standard deviation excerpted from Kassab et al. 2014[9]. 
 
In Table 12 the comparison of the transient solution to the steady state solution through 
the evaluation of the two population Z-score. For the intermediate geometry simulation releasing 
2.5mm particles we see that the means for the total amount of particles traveling to the cerebral 
vessels turn out to not to be comparable has the null hypothesis is rejected. This is mainly due to 
the fact that the interaction between the cannula jet and the aortic root flow do not behave 
similarly in either mode. For the transient case the jet experiences oscillations caused by the 
periodic aortic root flow, hence particles will not travel following similar patterns since 
pulsatility has been introduced. 
The perpendicular geometry on the other hand presents strong cannula jet impingement, 
which causes stagnation in the region. Due to the pulsatile nature of the flow entering from the 
aortic root, the jet tends to undergo marked fluctuations that can be clearly shown by the moving 
stagnation point on the aortic wall facing the cannula (Figure 26). These jet oscillations change 
 52 
the flow pattern of the continuous phase but more importantly drastically affect particle 
transition in the region. Due to the smaller size of the particles, cloths appear to be more 
responsive to flow pattern changes. This phenomenon is reflected in the rejection of the null 
hypothesis. 
 
 
Figure 31 - Stagnation point migration through systolic  phase. 
 
Figure 32 - Cardiac cycle. 
When releasing 3.5mm particles implementing an intermediate VAD suture means do not 
compare. In fact the means for the transient model show an opposite, increasing trend to the 
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steady state case. This is dictated by a similar phenomenon to the oscillating jet in the case of the 
perpendicular geometry. To a small degree the cannula jet suffers a pulsatile push-and pull from 
the aortic root, which coupled to the increased particle, size results in increased stroke chances as 
the particles get pushed into the cerebral vessels. 
In a perpendicular geometry the mean for stroke induced by 3.5mm particle compares to 
the steady state case. Again the oscillating jet phenomenon is strongly present; the increased 
particle size causes cloths to be increasingly affected by the flow field. Due to the large amount 
of momentum loss induced by the constant jet impingement, particles for the steady case and the 
transient case behave in much the same way. A Z-score rejecting the alternate hypothesis 
supports this observation. 
The aim of this study is to quantify stroke rate for a transient model scheme and compare 
the results to a similar experiment carried out under steady state conditions. This study however 
brings to light another phenomenon, which could be of particular interest and deserves a great 
deal of attention.  
Table 13 - 3.5mm particle data for Ascending Aorta in the perpendicular geometry. 
run % 
1 23.53 
2 13.33 
3 29.37 
4 34.36 
5 26.18 
mean 25.35 
st dev 7.01 
variance 25.35±7.01 
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As shown in Table 13 for a perpendicular cannula configuration there is a significant 
amount of particles recirculating in the ascending aorta region as a result of strong jet 
impingement. This raises concerns as such particles can potentially occlude the coronary arteries 
at the root of the aortic arch causing a heart attack. Further investigation may reveal additional 
techniques that could mitigate the strong vorticity and recirculation observed.   
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5 CHAPTER 5 
5.1 Conclusion 
 
It was established clearly from the steady state CFD computations it was clear that VAD 
cannula angle orientation configuration can greatly affect the fraction of thrombi originating 
from the VAD embolizing in the cerebral vessels [9]. Proper adjustment of the cannula 
implantation can potentially reduce stroke risk. The introduction of pulsatile flow shows, 
however, a change in the predictions brought forth by the steady state models. Cannula jet 
oscillations cannot be neglected as they dramatically change the flow field transporting the 
particles. In addition to stroke risk computations this study brings forth the possibility of further 
investigation in likely event of occlusion in vessels supplying blood to the cardiac muscles that 
may lead to heart attack which is an equally fatal occurrence. 
Hence we have additional insight on acceptable simplifications and required 
specifications that a predictive model would need in order to be reliable for medical applications. 
Depending on particle size and angle implementation, a steady state study may be sufficient 
while for other cases pulsatile flow is necessary to accurately depict flow pattern and 
embolization rates. 
5.2 Future Work 
 
The results provided by this procedure deemed to be quite realistic and provide a good 
approximation thrombo-embolization through particle tracking. As mentioned before, a 
particularity of this work was dictated by the lack of particle-to-particle interaction, which might 
reduce the degree of accuracy. However to reduce computational periods, this approximation 
was deemed necessary and appropriate. The next step to be taken is to consider partially elastic 
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wall-to-particle and particle-to-particle interactions dictated by restitution coefficients. This 
addition will ensure greater accuracy in the model. 
A further step will be to add fluid-to-structure interaction (FSI) that marks the transition 
between a rigid aortic model, to a compliant one. Such a degree of complexity will definitely set 
a new standard for circulatory modeling in the bioengineering field. In addition as a further 
method of validation, our group is currently working on a bench top model with compliant 
arterial and venous beds, which would closely match the simulated model discussed in this 
project. In order to implement compliance, Windkessels structures are included. The aortic artery 
will still be modeled having rigid walls; however adding bed compliance represents a definite 
step forward from previous work [1]. A pulsatile pump will generate a waveform and a 
continuous flow pump will simulate the LVAD. 
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APPENDIX A: EQUATIONS 
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(29) LPM ODEs D(y,t)=f 
In the following pages find the expression for the right hand side of equation 15. 
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 61 
 (30) Auxiliary current and reference voltage equations 
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APPENDIX B: FIGURES 
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Figure 33 - FULL LVAD circuit LPM 
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 APPENDIX C: TABLES 
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Table 14 - 2.5mm particle data for each outlet for Intermediate geometry. 
run injected DA % L_Cor % L_Vert % LCA % LSA % R_Cor % R_Vert % RCA % RSA % 
1 343 171 49.85 0 0.00 14 4.08 32 9.33 39 11.37 3 0.87 6 1.75 46 13.41 58 16.91 
2 348 158 45.40 2 0.57 7 2.01 42 12.07 30 8.62 2 0.57 7 2.01 50 14.37 59 16.95 
3 369 176 47.70 2 0.54 3 0.81 45 12.20 39 10.57 3 0.81 2 0.54 48 13.01 50 13.55 
4 385 139 36.10 1 0.26 6 1.56 56 14.55 40 10.39 1 0.26 4 1.04 46 11.95 41 10.65 
5 337 176 52.23 1 0.30 6 1.78 41 12.17 42 12.46 0 0.00 8 2.37 40 11.87 43 12.76 
tot 1782 2 46.0 
 
0.34 
 
2.02 
 
12.12 
 
10.66 
 
0.51 
 
1.52 
 
12.91 
 
14.09 
mean 
  
46.26 
 
0.33 
 
2.05 
 
12.06 
 
10.68 
 
0.50 
 
1.54 
 
12.92 
 
14.16 
st dev 
  
5.56 
 
0.21 
 
1.09 
 
1.65 
 
1.26 
 
0.33 
 
0.66 
 
0.94 
 
2.45 
variance 
  
46.26±5.56 
 
0.33±0.21 
 
2.05±1.09 
 
12.06±1.65 
 
10.68±1.26 
 
0.50±0.33 
 
1.54±0.66 
 
12.92±0.94 
 
14.16±2.45 
 
Table 15 - 2.5mm particle count at cerebral vessels for Intermediate geometry. 
run Vertebrals % Carotids % Overall % 
1 20 5.83 78 22.74 98 28.57 
2 14 4.02 92 26.44 106 30.46 
3 5 1.36 93 25.20 98 26.56 
4 10 2.60 102 26.49 112 29.09 
5 14 4.15 81 24.04 95 28.19 
tot 
 
3.54 
 
25.03 
 
28.56 
mean 
 
3.59 
 
24.98 
 
28.57 
st dev 
 
1.52 
 
1.44 
 
1.27 
variance 
 
3.59±1.52 
 
24.98±1.44 
 
28.57±1.27 
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Table 16 - 3.5mm particle data for each outlet for Intermediate geometry. 
run injected DA % L_Cor % L_Vert % LCA % LSA % R_Cor % R_Vert % RCA % RSA % 
1 368 128 34.78 0 0.00 5 1.36 55 14.95 30 8.15 1 0.27 3 0.82 31 8.42 31 8.42 
2 341 190 55.72 4 1.17 9 2.64 48 14.08 34 9.97 0 0.00 7 2.05 45 13.20 40 11.73 
3 326 161 49.39 4 1.23 11 3.37 50 15.34 41 12.58 3 0.92 7 2.15 52 15.95 43 13.19 
4 383 187 48.83 2 0.52 5 1.31 44 11.49 45 11.75 1 0.26 6 1.57 45 11.75 48 12.53 
5 377 181 48.01 8 2.12 5 1.33 44 11.67 38 10.08 4 1.06 4 1.06 44 11.67 51 13.53 
tot 1795 
 
47.19 
 
1.00 
 
1.95 
 
13.43 
 
10.47 
 
0.50 
 
1.50 
 
12.09 
 
11.87 
mean 
  
47.34 
 
1.01 
 
2.00 
 
13.50 
 
10.51 
 
0.50 
 
1.53 
 
12.20 
 
11.88 
st dev 
  
6.85 
 
0.72 
 
0.85 
 
1.62 
 
1.54 
 
0.41 
 
0.53 
 
2.44 
 
1.83 
variance 
  
47.34±6.85 
 
1.01±0.72 
 
2.00±0.85 
 
13.50±1.62 
 
10.51±1.54 
 
0.50±0.41 
 
1.53±0.53 
 
12.20±2.44 
 
11.88±1.83 
 
 
Table 17 - 3.5mm particle count at cerebral vessels for Intermediate geometry. 
run Vertebrals % Carotids % Overall % 
1 8 2.17 86 23.37 94 25.54 
2 16 4.69 93 27.27 109 31.96 
3 18 5.52 102 31.29 120 36.81 
4 11 2.87 89 23.24 100 26.11 
5 9 2.39 88 23.34 97 25.73 
tot 
 
3.45 
 
25.52 
 
28.97 
mean 
 
3.53 
 
25.70 
 
29.23 
st dev 
 
1.33 
 
3.19 
 
4.48 
variance 
 
3.53±1.33 
 
25.70±3.19 
 
29.23±4.48 
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Table 18 - 2.5mm particle count at each outlet for Perpendicular geometry. 
run injected DA % L_Cor % L_Vert % LCA % LSA % R_Cor % R_Vert % RCA % RSA % 
1 182 119 65.38 1 0.55 0 0 8 4.40 4 2.20 0 0.00 0 0.00 10 5.49 16 8.79 
2 125 87 69.60 1 0.80 1 0.8 3 2.40 1 0.80 1 0.80 2 1.60 4 3.20 6 4.80 
3 122 78 63.93 1 0.82 0 0 6 4.92 9 7.38 2 1.64 1 0.82 5 4.10 8 6.56 
4 175 106 60.57 0 0.00 0 0 8 4.57 6 3.43 2 1.14 0 0.00 8 4.57 5 2.86 
5 67 44 65.67 0 0.00 0 0 5 7.46 7 10.45 0 0.00 1 1.49 0 0.00 2 2.99 
tot 671 
 
64.68 
 
0.45 
 
0.15 
 
4.47  4.02 
 
0.75 
 
0.60  4.02 
 
5.51 
mean 
  
65.03 
 
0.43 
 
0.16 
 
4.75 
 
4.85 
 
0.72 
 
0.78 
 
3.47 
 
5.20 
st dev 
  
2.92 
 
0.37 
 
0.32 
 
1.62 
 
3.55 
 
0.64 
 
0.69 
 
1.89 
 
2.25 
variance 
  
65.03±2.92 
 
0.43±0.37 
 
0.16±0.32 
 
4.75±1.62 
 
4.85±3.55 
 
0.72±0.64 
 
0.78±0.69 
 
3.47±1.89 
 
5.20±2.25 
 
 
Table 19 - 2.5mm particle count at cerebral vessels for Perpendicular geometry. 
run Vertebrals % Carotids % Overall % 
1 0 0.00 18 9.89 18 9.89 
2 3 2.40 7 5.60 10 8.00 
3 1 0.82 11 9.02 12 9.84 
4 0 0.00 16 9.14 16 9.14 
5 1 1.49 5 7.46 6 8.96 
tot 
 
0.75 
 
8.49 
 
9.24 
mean 
 
0.94 
 
8.22 
 
9.16 
st dev 
 
0.92 
 
1.53 
 
0.69 
variance 
 
0.94±0.92 
 
8.22±1.53 
 
9.16±0.69 
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Table 20 - 3.5mm particle count at each outlet for Perpendicular geometry. 
run injected DA % L_Cor % L_Vert % LCA % LSA % R_Cor % R_Vert % RCA % RSA % 
1 68 36 52.94 0 0.00 0 0.00 2 2.94 4 5.88 0 0.00 1 1.47 2 2.94 0 0.00 
2 57 21 36.84 0 0.00 0 0.00 4 7.02 1 1.75 0 0.00 0 0.00 3 5.26 1 1.75 
3 126 93 73.81 0 0.00 0 0.00 10 7.94 9 7.14 0 0.00 1 0.79 5 3.97 6 4.76 
4 61 46 75.41 0 0.00 0 0.00 4 6.56 2 3.28 0 0.00 0 0.00 2 3.28 4 6.56 
5 61 47 77.05 0 0.00 0 0.00 6 9.84 7 11.48 0 0.00 1 1.64 3 4.92 2 3.28 
tot 373 
 
49.59 
 
0.00 
 
0.00 
 
5.31 
 
4.69 
 
0.00 
 
0.61 
 
3.06 
 
2.65 
mean 
  
63.21 
 
0.00 
 
0.00 
 
6.86 
 
5.91 
 
0.00 
 
0.78 
 
4.07 
 
3.27 
st dev 
  
15.83 
 
0.00 
 
0.00 
 
2.26 
 
3.37 
 
0.00 
 
0.70 
 
0.90 
 
2.28 
variance 
  
63.21±15.83 
 
0.00±0.00 
 
0.00±0.00 
 
6.86±2.26 
 
5.91±3.37 
 
0.00±0.00 
 
0.78±0.70 
 
4.07±0.90 
 
3.27±2.28 
 
 
Table 21 - 3.5mm particle count at cerebral vessels for Perpendicular geometry. 
run Vertebrals % Carotids % Overall % 
1 1 1.47 4 5.88 5 7.35 
2 0 0.00 7 12.28 7 12.28 
3 1 0.79 15 11.90 16 12.70 
4 0 0.00 6 9.84 6 9.84 
5 1 1.64 9 14.75 10 16.39 
tot 
 
0.61 
 
8.37 
 
8.98 
mean 
 
0.78 
 
10.93 
 
11.71 
st dev 
 
0.70 
 
2.97 
 
3.02 
variance 
 
0.78±0.70 
 
10.93±2.97 
 
11.71±3.02 
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APPENDIX D: CODES 
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Coupling Code  
 
package macro; 
 
import java.nio.file.*; 
import static java.nio.file.StandardCopyOption.*; 
import java.nio.file.attribute.*; 
import static java.nio.file.FileVisitResult.*; 
import java.io.IOException; 
import java.util.*; 
 
import star.common.*; 
import star.base.neo.*; 
import star.vis.*; 
import java.io.*; 
import java.net.*; 
 
 
// Note: To get macro commands from the CFD simply hit the record button and save the Java file. Once you are done with the in software commands, hit stop and all the 
// commands will be saved in the Java file you created. These commands can be used below. 
 
public class FontanCoupler extends StarMacro 
{ 
  // USER_TODO: Change the following configuration variables; Note that these variables must match the configuration of the RK solver 
   
  // Number of heart cycles to run 
 public int num_cycles = 10; 
   
  // Number of time steps per heart cycle (CFD) 
 public int steps_per_cycle = 1200; 
 
  // Number of time step per heart cycle (LPM) 
 public int LPM_steps_per_cycle = 8000; 
 
  // Heart rate 
 public double heart_rate = 80.0; 
  
  // Number of solver iterations per solver timestep (i.e. 50 iterations/time step)  
 public int iters_per_step = 250; 
 public int iters_per_step_final = 200; 
  
  // Absolute file path of the compiled RK executable 
   
 //public String rkExePath = "/New_Fontan_RK/BIN/RK_Fontan.exe";   
 public String rkExePath = "C:\\Users\\ra400879\\Desktop\\New_Fontan_RK_Ray\\BIN\\RK_Fontan.exe"; 
 //public String rkExePath = "/share/CERT/Fontan_Models/Baseline_Batch_Testing/New_Fontan_RK/BIN/RK_Fontan.exe.lnk"; 
  
  // Absolute file path of the table output by the RK executable 
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 //public String rkOutputTablePath = "/New_Fontan_RK/BIN/Outputs/Fontan.csv"; 
 //public String rkOutputTablePath = "c:/Users/ra400879/Desktop/New_Fontan_RK_Ray/BIN/Outputs/LVAD.csv"; 
 public String rkOutputTablePath = "/share/CERT/Ray_Thesis/New_Fontan_RK_Ray/BIN/Outputs/LVAD.csv"; 
 
  // Absolute file path of the sim file 
 //public String simPath = "/Baseline_Simulation_V2.0/Basline-V2.2_Copy.sim"; 
 public String simPath = "/share/CERT/Ray_Thesis/StarCCM_Simulation/LVAD_Unsteady_CO_4_1_perpendicular.sim"; 
   
 //public String simPath = "/share/CERT/Ray_Thesis/StarCCM_Simulation/LVAD_Unsteady_CO_4_1_perpendicular.sim"; 
  
  // Absolute file path of the table output from Star-CCM+ that is used by the RK solver for coupling 
 //public String cfdOutputTablePath = "/New_Fontan_RK/BIN/PressOut.csv"; 
 public String cfdOutputTablePath = "C:/Users/ra400879/Desktop/New_Fontan_RK_Ray/BIN/CFDOut.csv"; 
   
 //public String cfdOutputTablePath = "/share/CERT/Ray_Thesis/New_Fontan_RK/BIN/Outputs/CFDOut.csv"; 
 
  // USER_TODO: End changing configuration variables 
  
  // Calculated time step length 
 public double dt = 60.0/heart_rate/steps_per_cycle; //  (60.0 s)/HR/NUM_STEPS 
 
 public void execute() 
 { 
  // Set the time step length based on the value calculated above 
  setTimestep(); 
 
  for(int i = 0; i < num_cycles; i++) 
  { 
   runRK(); 
  
   // Run a CFD/LPM steps per cycle 
 
   mFile(); 
     
   runSim(); 
            
        // Output values from Star-CCM+ for coupling 
   updateRKInputs(); 
    
      // Backup the simulation's state after each cycle 
   backupCycle(i); 
 
  } 
 } 
  
 public void setTimestep() 
 { 
  // Set the time step length based on the value calculated above 
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  Simulation sim = getActiveSimulation(); 
  ImplicitUnsteadySolver unsteadySolver = (ImplicitUnsteadySolver) sim.getSolverManager().getSolver(ImplicitUnsteadySolver.class); 
 
  unsteadySolver.getTimeStep().setValue(dt); 
 } 
 
 public void runRK() 
 { 
  try 
  { 
 
   // Define the location of the RK solver executable 
   File rkExe = new File(rkExePath); 
 
   ProcessBuilder rkpb = new ProcessBuilder(rkExe.getAbsolutePath()); 
 
   // Define the working directory of the RK solver 
   rkpb.directory(new File(rkExe.getParent())); 
 
   System.out.println("About to start RK solver"); 
    
   Process rkp = rkpb.start(); 
 
   // This is the waiting function that will wait for your RK Solver to finish before starting the sim 
    
   InputStream in = rkp.getInputStream(); 
   in.close(); 
   OutputStream out = rkp.getOutputStream(); 
   out.close(); 
   InputStream error = rkp.getErrorStream(); 
   error.close(); 
   rkp.waitFor(); 
   rkp.destroy(); 
    
 
   System.out.println("Finished RK solver"); 
  } 
  catch(Exception e) 
  { 
   System.out.println("Error while running RK solver: " + e.toString()); 
  } 
 } 
  
 public static void mFile()  
 {   
         try  
  {    
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              // File (or Directory) to be moved   
              Path src_Path = Paths.get("c:\\Users\\ra400879\\Desktop\\New_Fontan_RK_Ray\\BIN\\Outputs\\LVAD.csv");   
   
              // Destination directory   
              Path dest_Path = Paths.get("z:\\CERT\\Ray_Thesis\\New_Fontan_RK_Ray\\BIN\\Outputs\\LVAD.csv");  
    
   // Move file to a new directory 
   Files.copy(src_Path, dest_Path, REPLACE_EXISTING); 
    
   System.out.println("Move successful");   
   
         } 
  catch (Exception ex) 
  {   
              System.out.println(ex);   
         }   
    } 
 
 public void runSim() 
 { 
  Simulation sim = getActiveSimulation(); 
  Solution solution_0 = sim.getSolution(); 
  solution_0.clearSolution(Solution.Clear.History); 
  System.out.println("History cleared"); 
 
 // This is where the CFD solver updates its boundary conditions based on the table of outputs that the RK solver writes out, The actual file that the RK solver 
puts out needs 
 // to be set up in the CFD, under Tools.Tables , In this instance the Table is named BCs 
  FileTable bcs = (FileTable) sim.getTableManager().getTable("LVAD"); 
  bcs.setFileName(rkOutputTablePath); 
  bcs.extract(); 
 
 // Run one timestep in the CFD 
  InnerIterationStoppingCriterion innerIters = (InnerIterationStoppingCriterion) 
(sim.getSolverStoppingCriterionManager().getSolverStoppingCriterion("Maximum Inner Iterations")); 
 
  innerIters.setMaximumNumberInnerIterations(iters_per_step); 
  sim.getSimulationIterator().step(1); 
 
  innerIters.setMaximumNumberInnerIterations(iters_per_step_final); 
  sim.getSimulationIterator().run(); 
 
   
 } 
 
 // Backs up the current version of the simulation in a new folder 
   // called "<sim's parent directory>- Cycle #" 
 public void backupCycle(int cycleNum) 
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 {  
  System.out.println("Started backup of cycle #" + cycleNum);   
  File simFile = new File(simPath); 
 
  Path srcDir = Paths.get(simFile.getParent()); 
  Path destDir = Paths.get(simFile.getParent() + String.format("- Cycle %d", cycleNum)); 
   
  try 
  { 
   copyDirRecursive(srcDir, destDir); 
 
   System.out.println("Finished backup of current cycle"); 
  } 
  catch(Exception e) 
  { 
   System.out.println("Error occured while backing up current cycle: " + e); 
  } 
 } 
  
  
 // Program to update the Lumped model with new resistances for the Lumped parameter model (RK solver) 
 public void updateRKInputs() 
 { 
  Simulation sim = getActiveSimulation(); 
 
        // grabs the Table that starccm creates in the softwares itself. In this instance the name of the table is "PressOut" 
        // This PressOut is located in the plots sections of the CFD 
  MonitorPlot plot = ((MonitorPlot) sim.getPlotManager().getObject("CFDOut")); 
 
        // takes that table and outputs to a csv file 
  plot.export(resolvePath(cfdOutputTablePath), ","); 
 } 
 
 // Recursively copies the contents of srcDir to destDir 
 public void copyDirRecursive(final Path srcDir, final Path destDir) throws IOException 
 { 
  EnumSet options = EnumSet.of(FileVisitOption.FOLLOW_LINKS); 
 
  if(Files.isDirectory(srcDir)) 
  { 
   Files.walkFileTree(srcDir, options, Integer.MAX_VALUE, new FileVisitor<Path>() { 
 
    @Override 
    public FileVisitResult postVisitDirectory(Path dir, IOException exc) throws IOException  
    { 
     return FileVisitResult.CONTINUE; 
    } 
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    @Override 
    public FileVisitResult preVisitDirectory(Path dir, BasicFileAttributes attrs)   
    { 
     CopyOption[] opt = new CopyOption[]{COPY_ATTRIBUTES,REPLACE_EXISTING}; 
 
     Path newDirectory = destDir.resolve(srcDir.relativize(dir)); 
 
     try 
     { 
      Files.copy(dir, newDirectory, opt); 
     } 
     catch(FileAlreadyExistsException x) 
     { 
 
     } 
     catch(IOException x) 
     { 
      return FileVisitResult.SKIP_SUBTREE; 
     } 
 
     return CONTINUE; 
    } 
 
    @Override 
    public FileVisitResult visitFile(Path file, BasicFileAttributes attrs) throws IOException  
    { 
        copyFile(file, destDir.resolve(srcDir.relativize(file))); 
            return CONTINUE; 
    } 
 
    @Override 
    public FileVisitResult visitFileFailed(Path file, IOException exc) throws IOException  
    { 
     return CONTINUE; 
    } 
   }); 
  } 
 } 
 
 public static void copyFile(Path src, Path dest) throws IOException 
 { 
        CopyOption[] options = new CopyOption[]{REPLACE_EXISTING,COPY_ATTRIBUTES}; 
        Files.copy(src, dest, options); 
    } 
} 
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